Fluorene

Fluorene

SCHEMBL2552764

O=C(O)/C=C/c1ccccc1.c1ccc2c(c1)Cc1ccccc1-2

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.68
HDAC3 O15379 2/20 0.68
HDAC4 P56524 2/20 0.68
HDAC1 Q13547 2/20 0.68
HDAC2 Q92769 2/20 0.68
HDAC8 Q9BY41 2/20 0.68
HDAC6 Q9UBN7 2/20 0.68
TNKS O95271 1/20 0.68
HDAC7 Q8WUI4 1/20 0.68
HDAC10 Q969S8 1/20 0.68
HDAC11 Q96DB2 1/20 0.68
TNKS2 Q9H2K2 1/20 0.68
HDAC9 Q9UKV0 1/20 0.68
HDAC5 Q9UQL6 1/20 0.68
CYP1A2 P05177 3/20 0.52
CYP3A4 P08684 2/20 0.52
HSD17B10 Q99714 1/20 0.52
MAPT P10636 4/20 0.52
LMNA P02545 3/20 0.52
ALDH1A1 P00352 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluorene SCHEMBL2552766 1.00 HCAR2 (0.68) HCAR2HDAC3HDAC4HDAC1HDAC2
Fluorene SCHEMBL29688050 1.00 HCAR2 (0.68) HCAR2HDAC3HDAC4HDAC1HDAC2
SCHEMBL11817036 0.87 MAPT (0.60) HCAR2HDAC3HDAC4HDAC1HDAC2
SCHEMBL11817041 0.87 MAPT (0.60) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL1332 0.82 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL653827 0.82 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL50466 0.82 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL653828 0.82 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL1706935 0.82 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2
Cinnamic Acid SCHEMBL3406486 0.82 HCAR2 (1.00) HCAR2HDAC3HDAC4HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130090031-A1 COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF FERRANIA TECHNOLOGIES S.P.A. (IT) 2013-04-11 US disclosed
EP-2556113-A1 COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF Ferrania Technologies S.p.A. (IT) 2013-02-13 EP disclosed
EP-2556113-A1 COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF Ferrania Technologies S.p.A. (IT) 2013-02-13 EP disclosed
WO-2011124522-A1 COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF FERRANIA TECHNOLOGIES S.P.A. (IT) 2011-10-13 WO disclosed
WO-2011124522-A1 COMPOSITE FILM MATERIAL COMPRISING A RESIN OF FLUORENE CROTONATE, FLUORENE CINNAMATE, FLUORENE ACRYLATE, FLUORENE METHACRYLATE, FLUORENE ALLYLETHER OR A COMBINATION THEREOF FERRANIA TECHNOLOGIES S.P.A. (IT) 2011-10-13 WO disclosed
EP-1819648-B1 PHOTOREACTIVE COMPOUND, LIQUID CRYSTAL ALIGNMENT LAYER USING THE COMPOUND, METHOD OF MANUFACTURING THE ALIGNMENT LAYER, AND LIQUID CRYSTAL DISPLAY DEVICE CONTAINING THE ALIGNMENT LAYER LG CHEMICAL LTD (KR) 2009-04-15 EP disclosed
US-7422778-B2 Photoreactive compound, liquid crystal alignment layer using the compound, method of manufacturing the alignment layer, and liquid crystal display device containing the alignment layer LG CHEM, LTD. (KR) 2008-09-09 US disclosed
EP-1819648-A4 PHOTOREACTIVE COMPOUND, LIQUID CRYSTAL ALIGNMENT LAYER USING THE COMPOUND, METHOD OF MANUFACTURING THE ALIGNMENT LAYER, AND LIQUID CRYSTAL DISPLAY DEVICE CONTAINING THE ALIGNMENT LAYER LG CHEMICAL LTD (KR) 2008-02-13 EP disclosed
EP-1819648-A1 PHOTOREACTIVE COMPOUND, LIQUID CRYSTAL ALIGNMENT LAYER USING THE COMPOUND, METHOD OF MANUFACTURING THE ALIGNMENT LAYER, AND LIQUID CRYSTAL DISPLAY DEVICE CONTAINING THE ALIGNMENT LAYER LG Chemical Ltd. (KR) 2007-08-22 EP disclosed
US-20060121213-A1 Photoreactive compound, liquid crystal alignment layer using the compound, method of manufacturing the alignment layer, and liquid crystal display device containing the alignment layer LG CHEM, LTD. (KR) 2006-06-08 US disclosed
WO-2006059884-A1 PHOTOREACTIVE COMPOUND, LIQUID CRYSTAL ALIGNMENT LAYER USING THE COMPOUND, METHOD OF MANUFACTURING THE ALIGNMENT LAYER, AND LIQUID CRYSTAL DISPLAY DEVICE CONTAINING THE ALIGNMENT LAYER LG CHEM, LTD. (KR) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060121213-A1 Photoreactive compound, liquid crystal alignment layer using the compound, method of manufacturing the alignment layer, and liquid crystal display device containing the alignment layer CRY1, C9, CXCR1 HCAR2 3815/4885HDAC3 4836/4885HDAC4 4767/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.